Warriors versus worriers: The role of COMT gene variants

CNS Spectrums

Volumn 11, Issue 10, 2006, Pages 745-748

  Stein, Dan J ^a,b   Newman, Timothy K ^a   Savitz, Jonathan ^a   Ramesar, Rajkumar ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE; METHIONINE; VALINE;

AFFECT; ALLELE; AMINO ACID SUBSTITUTION; ANXIETY; ANXIETY DISORDER; ARTICLE; AVERSION; CODON; COGNITION; COMT GENE; DISEASE ASSOCIATION; DOPAMINE RELEASE; GENE; GENETIC VARIABILITY; HUMAN; MEMORY; NERVE CELL; NEUROCHEMISTRY; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 33750028470     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900014863     Document Type: Article

References (37)

1. Stein DJ, Moeller FG. The man who turned bad. CNS Spectr. 2005;10:88-90.
2. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry. 2003;160:1041-1052.
3. Stein DJ, Hollander E. Impulsive aggression and obsessive-compulsive disorder. Psychiatr Ann. 1993;23:389-395.
4. Stein DJ. Neurobiology of the obsessive-compulsive spectrum disorders. Biol Psychiatry. 2000;47:296-304.
5. Winterer G, Musso F, Vucurevic G, et al. COMT genotype predicts BOLD signal and noise characteristics in prefrontal circuits. Neuroimage. 2006 Jul 31; [Epub ahead of print].
6. Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001;98:6917-6922.
7. Goldberg TE, Egan MF, Gscheidle T, et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry. 2003;60:889-896.
8. Blasi G, Mattay VS, Bertolino A, et al. Effect of catechol-O- methyltransferase val158met genotype on attentional control. J Neurosci 2005;25:5038-5045.
9. Bishop SJ, Cohen JD, Fossella J, et al. COMT genotype influences prefrontal response to emotional distraction. Cogn Affect Behav Neurosci. 2006;6:62-70.
10. Zubieta JK, Heitzeg MM, Smith YR, et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science. 2003;299:1240-1243.
11. Smolka MN, Schumann G, Wrase J, et al. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci. 2005;25:836-842.
12. Kates WR, Antshel KM, Abdulsabur N, et al. A gender-moderated effect of a functional COMT polymorphism on prefrontal brain morphology and function in velo-cardio-facial syndrome (22q11.2 deletion syndrome). Am J Med Genet B Neuropsychiatr Genet 2006;141:274-280.
13. Zinkstok J, Schmitz N, van Amelsvoort T, et al. The COMT val(158)met polymorphism and brain morphometry in healthy young adults. Neurosci Lett. 2006;405:34-39.
14. Meyer-Lindenberg A, Kohn PD, Kolachana B, et al. Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci. 2005;8:594-596.
15. Bilder RM, Volavka J, Czobor P, et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry. 2002;52:701-707.
16. Malhotra AK, Kestler LJ, Mazzanti C, et al. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 2002;159:652-654.
17. Heinz A, Smolka MN, The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Rev Neurosci. 2006;17:359-367.
18. Xu K, Ernst M, Goldman D. Imaging genomics applied to anxiety, stress response, and resiliency. Neuroinformatics. 2006;4:51-64.
19. Tunbridge EM, Harrison PJ Weinberger DR. Catechol-o-Methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry. 2006;60:141-151.
20. Olsson CA, Anney RJ, Lotfi-Miri M, et al. Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health. Psychiatr Genet. 2005;15:109-115.
21. Diatchenko L, Slade GD, Nackley AG, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005;14:135-143.
22. McGrath M, Kawachi I, Ascherio A, et al. Association between catechol-O-methyltransferase and phobic anxiety. Am J Psychiatry. 2004;161:1703-1705.
23. Munafo MR, Bowes L, Clark TG, et al. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry. 2005;10:765-770.
24. Mattay VS, Goldberg TE, Fera F, et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA. 2003;100:6186-6191.
25. Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57:1117-1127.
26. Mill J, Dempster E, Caspi A, et al. Evidence for monozygotic twin (MZ) discordance in methylation level at two CpG sites in the promoter region of the catechol-O-methyltransferase (COMT) gene. Am J Med Genet B Neuropsychiatr Genet. 2006;141:421-425.
27. van Praag HM, Asnis GM, Kahn RS, et al. Monoamines and abnormal behaviour. A multi-aminergic perspective. Br J Psychiatry. 1990;157:723-734.
28. Weickert TW, Goldberg TE, Mishara A, et al. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Biol Psychiatry. 2004;56:677-682.
29. Arias B, Serretti A, Lorenzi C, et al. Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. J Affect Disord. 2006;90:251-256.
30. Bertolino A, Caforio G, Blasi G, et al. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry. 2004;161:1798-1805.
31. Lee MS, Kim HS, Cho EK, et al. COMT genotype, and effectiveness of entacapone in patients with fluctuating Parkinson's disease. Neurology. 2002;58:564-567.
32. Yamanouchi Y, Iwata N, Suzuki T, et al. Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone. Pharmacogenomics J. 2003;3:356-361.
33. Rakvag TT, Klepstad P, Baar C, et al. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain. 2005;116:73-78.
34. Craddock N, Owen MJ, O'Donovan MC. The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Mol Psychiatry. 2006;11:446-458.
35. De Luca V, Tharmalingam S, Sicard T, Kennedy JL. Gene-gene interaction between MAOA and COMT in suicidal behavior. Neurosci Lett. 2005;383:151-154.
36. Zahn-Waxler C. Warriors and worriers: gender and psychopathology. Dev Psychopathol. 1993;5:79-89.
37. Brook JS, Whiteman M, Cohen P. Warriors and worriers: a longitudinal study of gender differences in drug use. NIDA Research Monographs. 2000;271-284.